Intel surges as Nvidia takes $5B stake
A group of GTCR funds, including GTCR Fund XI/A LP, GTCR Fund XI/C LP, and GTCR Co-Invest XI LP, collectively sold 8,000,000 shares of Sotera Health Co (NASDAQ:SHC) common stock on September 5, 2025. The shares were sold at a price of $15.111, totaling $120,888,000. The sale comes as Sotera Health, currently valued at $4.5 billion, trades near its 52-week high of $16.99, having gained nearly 34% over the past six months. InvestingPro analysis shows the company maintains a GOOD financial health score, with 12 additional key insights available to subscribers.
Following the sale, the GTCR XI Funds directly hold 41,215,301 shares of Sotera Health Co .
GTCR Partners XI/A&C LP is the general partner of GTCR Fund XI/A and GTCR Fund XI/C. GTCR Investment XI LLC is the general partner of GTCR Co-Invest XI and GTCR Partners XI/A&C.
In other recent news, Sotera Health reported impressive financial results for the second quarter of 2025, surpassing analyst forecasts with an adjusted earnings per share (EPS) of $0.20, compared to the expected $0.17. The company’s revenue also exceeded predictions, reaching $294.34 million against the projected $275.89 million. Additionally, Jefferies increased its price target for Sotera Health to $16.00, citing a strong performance across all business segments. Barclays also raised its price target from $13.00 to $17.00, maintaining an Overweight rating. In a separate development, certain stockholders, including affiliates of Warburg Pincus LLC and GTCR LLC, sold 20 million shares of Sotera Health in a secondary offering. Sotera Health did not issue or sell any shares in this transaction and will not receive proceeds from the sale. However, the company will cover expenses related to the offering under its Amended and Restated Registration Rights Agreement. These developments reflect a period of significant activity and interest in Sotera Health’s financial and market performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.